Oncopharmpod
Afamitresgene Autoleucel & Vorasidenib
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:12:29
- Mas informaciones
Informações:
Sinopsis
A new cellular therapy is approved for synovial sarcoma and the anticipated approval has occurred for the dual IDH1/IDH2 inhibitor, vorasidenib.
